WHYUS
We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.
NewsEvents
We are delighted that positive outcomes of our contribution to the “Magic Bullet” project developed under the Marie Skłodowska-Curie Actions…
European IN Cell User Meeting
Our Director of High Throughput Biology and Screening, Alberto Bresciani, will be attending the European IN Cell User Meeting from…
AACR Annual Meeting 2019
On March 29-April 3, Carlo Toniatti (CSO) and Dan Conlon (VP of Business Development, North America) will be attending AACR…
EASL 2019
On April 10-14, Vincenzo Summa (VP Drug Discovery), Leda Bencheva (Research Scientist) will be attending EASL 2019 in Vienna, Austria.…
IRBMPHOTOS
